SEC Comment Letter 0000000000-23-008263 to Telesis Bio Inc. (TBIO) (CIK 0001850079)
Telesis Bio Inc. (TBIO) (CIK 0001850079)
Date: Aug. 2, 2023 · CIK: 0001850079 · Accession: 0000000000-23-008263
AI Filing Summary & Sentiment
File numbers found in text: 333-273491
Letter
United States securities and exchange commission logo August 2, 2023 Todd Nelson Chief Executive Officer Telesis Bio Inc. 10431 Wateridge Circle, Suite 150 San Diego, California 92121 Re:Telesis Bio Inc. Registration Statement on Form S-3 Filed July 27, 2023 File No. 333-273491 Dear Todd Nelson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Ansart at 202-551-4511 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Jesse Shumaker
Show Raw Text
United States securities and exchange commission logo
August 2, 2023
Todd Nelson
Chief Executive Officer
Telesis Bio Inc.
10431 Wateridge Circle, Suite 150
San Diego, California 92121
Re:Telesis Bio Inc.
Registration Statement on Form S-3
Filed July 27, 2023
File No. 333-273491
Dear Todd Nelson:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Ansart at 202-551-4511 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Jesse Shumaker